<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20200501</date><key>pmc.key</key><document><id>3400371</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.1155/2012/454601</infon><infon key="article-id_pmc">3400371</infon><infon key="article-id_pmid">22848829</infon><infon key="elocation-id">454601</infon><infon key="license">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="name_0">surname:Osungbade;given-names:Kayode O.</infon><infon key="name_1">surname:Oladunjoye;given-names:Adeolu O.</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2012</infon><infon key="year">2012</infon><offset>0</offset><text>Preventive Treatments of Iron Deficiency Anaemia in Pregnancy: A Review of Their Effectiveness and Implications for Health System Strengthening</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>144</offset><text> Objectives. We conducted a review of effectiveness of preventive treatments of iron deficiency anaemia in pregnancy in developing countries and highlighted their constraints as well as interventions required to strengthen the health services. Methods. Literature from Pubmed (MEDLINE), AJOL, Google Scholar, and Cochrane database was reviewed. Results. Evidence-based preventive treatment options for iron deficiency anaemia in pregnancy include prophylaxis iron supplements and food fortification with iron. Evidence abounds on their effectiveness in reducing the prevalence of iron deficiency anaemia in pregnancy. However, these prospects are threatened by side effects of iron supplements, low utilization of maternal health service in developing countries, partial implementation of preventive treatments, and weak infrastructure and political commitment to implement mass fortification of local staple foods by national governments. Conclusion. Sustainability of effectiveness of preventive treatments of iron deficiency anaemia in pregnancy could be achieved if the identified threats are adequately addressed.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1263</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1279</offset><text>Iron deficiency anaemia is defined as anaemia accompanied by depleted iron stores and signs of a compromised supply of iron to the tissues. There is variation in haemoglobin levels during pregnancy; at the beginning of a pregnancy, there is a normal reduction in haemoglobin level followed by a slight rise towards the end of pregnancy. The initial reduction has been explained to result from increased red cell mass and demands of the fetus which exceeds iron intake with consequent reduction in iron stores of the woman's body. Thus, the World Health Organization has defined anaemia in pregnancy as a haemoglobin value below 11âg/dL.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1918</offset><text>There are two known factors which contribute to development of iron deficiency anaemia (IDA) in pregnancy; the first is the woman's iron stores at the time of conception and the second is the amount of iron absorbed during gestation. The fact that anaemia frequently does occur in pregnancy among women in developing countries is an indication that preexisting iron stores are often inadequate and physiological adaptations to pregnancy are insufficient to meet the increased requirements. Hence, iron supplementation in pregnancy has become a standard and routine practice as a preventive treatment for iron deficiency anaemia in pregnancy in developing countries. In view of the foregoing, a review of effectiveness of preventive treatments of iron deficiency anaemia in pregnancy was conducted; furthermore, constraints were highlighted and suggestions for improvement were provided. </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2806</offset><text>2. Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2817</offset><text>We conducted a review of literature on evidence-based preventive treatments of iron deficiency anaemia in pregnancy with particular reference to developing countries. The following search terms were used: prevalence, burden, iron deficiency, anaemia in pregnancy, preventive treatments, and developing countries. Cross-sectional, observational, and randomized control trials' literature on the subject published between 2000 and 2011 served as the main sources of information. These works of literature were obtained from the commonly used medical databases such as PubMed (Medline), AJOL, and Google Scholar; in addition, Cochrane Library was used as source for systematic reviews on the subject matter.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3522</offset><text>The search generated 27 related articles in the following categories: prevalenceâ2, treatmentsâ8, reviewsâ6, interventions/trialsâ6, dosageâ1, and technical reportsâ4. This paper was limited to the six randomised and quasi-randomised trials (listed in Table 1) on preventive treatments of iron deficiency anaemia in pregnancy, which met at least one of the following inclusion criteria: (i) comparison between daily routine oral supplementation with iron or ironfolic acid and no supplementation/placebo; (ii) comparison between daily routine oral supplementation with iron or ironfolic acid and routine-intermittent (weekly and twice weekly) regimens; (iii) comparison between intermittent oral iron or ironfolic acid supplementation and no supplementation/placebo; (iv) comparison between intravenous route versus oral route of iron supplementation; (v) comparison between food fortification with iron and no fortification/placebo.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4468</offset><text>3. Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>4479</offset><text>3.1. Prevalence and Burden of Iron Deficiency Anaemia in Pregnancy in Developing Countries</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4570</offset><text>Worldwide, anemia affects over two billion people and the World Health Organization (WHO) has estimated that half of these are due to iron deficiency. Iron deficiency is not only the most prevalent but also the most neglected nutrient deficiency in the world, particularly among pregnant women and children in developing countries. Presently, over 40 million pregnant women suffer from iron deficiency (ID) and its consequences in developing countries. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5024</offset><text>Iron deficiency is the most common cause of anaemia in pregnancy. Iron deficiency anaemia accounts for 75â95% of cases of anaemia in pregnancy. Iron-deficiency anaemia, the late manifestation of chronic iron deficiency, is thought to be the most common nutrient deficiency among pregnant women. Studies conducted on pregnant women in Zimbabwe, China, India, and Mexico from 1996 to 2008 indicated that between 43% and 73% of the women were iron deficient (usually diagnosed as a low-ferritin concentration); out of these, 7% to 33% had IDA. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5568</offset><text>Among pregnant women, IDA has been associated with increased risks of low birth weight, prematurity, and maternal morbidity. UNICEF has reported deaths of an estimated 50,000 young women per year globally in pregnancy and childbirth due to severe iron deficiency anemia. The high frequency of iron deficiency anaemia in the developing countries has substantial health and economic cost implications. An analysis of 10 developing countries reported $0.32 per head or 0.57% of gross domestic product as a median value of physical productivity loss per year resulting from iron deficiency. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>6156</offset><text>3.2. Evidence-Based Preventive Treatment Options</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>6205</offset><text>3.2.1. Prophylaxis Iron Supplements</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6241</offset><text>The high physiological requirement for iron in pregnancy is difficult to meet with most diets; this is so especially in developing countries where food requirement is a problem. During pregnancy, iron requirements are not uniform. In the first trimester, daily needs decrease due to the absence of menstruation; thereby saving about 0.56âmg of iron per day, or 160âmg for the pregnancy. In the second trimester, blood volume increases by 45% with an increase in plasma volume of 50%; red cell mass is raised by 35% which amounts to about 450âmg of iron in a 55âkg woman. Fetal demands for iron are maximal during the third trimester and these are estimated at about 270âmg in a 3âkg fetus. Therefore, an average daily dose of 4â6âmg of iron is required in the second and third trimesters of pregnancy. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7060</offset><text>Overall, a woman requires about 2â2.8âmg of iron per day during pregnancy. But she will need to consume much more to obtain this daily requirement (i.e., between 20 and 48âmg of dietary iron). However, literature has presented different views on iron requirements during pregnancy ranging from 450 to 1,150âmg with a median of 790âmg. Since these requirements are difficult to meet through an ordinary diet, especially in developing countries where most diets do not contain adequate bioavailable iron, routine iron supplementation in pregnancy has been found to be of immense benefit.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7656</offset><text>Iron deficiency in nonpregnant populations can be measured quite precisely using laboratory tests such as serum ferritin, serum iron, transferrin, transferrin saturation, and transferrin receptors. However, there is a limitation to the use of some of these biochemical indicators of iron status in certain settings and conditions; thus, necessitating caution in their interpretations. For example, serum ferritin level, being an acute-phase protein, is raised in associated underlying infections and long-term diseases; it can therefore give a false normal or high level in a state of iron deficiency. Whereas in pregnancy, serum ferritin levels decline even in women ingesting daily supplements of iron. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8362</offset><text>There are different forms of preventive treatment of iron deficiency anaemia in pregnancy. Iron supplements can be given by mouth and parenteral route as intramuscular and intravenous injections; in addition, it can be administered as blood transfusion and recombinant erythropoietin with iron. The first choice in the prophylaxis of iron deficiency anaemia for almost all women is oral iron replacement because of its effectiveness, safety, and low cost. Oral iron, either as iron sulphate or fumarate, is the most commonly used preventive treatment for iron deficiency and iron deficiency anaemia in pregnancy. Direct iron supplementation has been extensively used in most developing countries as an intervention to prevent iron deficiency and consequently anaemia during pregnancy. Thus, preventive treatment with iron supplements has always been given in combination with folic acid and this has been included as part of routine antenatal care provided to pregnant women at every visit in developing countries. The rationale for this combination is to meet increased folic acid requirements in pregnancy brought about by the rapidly dividing cells in the fetus and elevated urinary losses. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9557</offset><text>The International Nutritional Anaemia Consultative Group had recommended a daily dose of 60âmg of iron for pregnant nonanaemic women, if supplementation for more than six months is possible before delivery. An increased daily dose of 120âmg of iron is further suggested if the duration of supplementation in pregnant nonanaemic women is shorter or where the prevalence of iron deficiency in women is high or in settings where pregnant women are generally anaemic. This supplement should include 400âÎ¼g of folic acid or lower doses, if this amount is not available. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>10130</offset><text>3.2.2. Food Fortification with Iron</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10166</offset><text>Iron fortification involves the addition of iron, usually with folic acid, to an appropriate food vehicle that is made available to the population at large. Food fortification with iron has thus become a promising approach for preventing iron deficiency anaemia in pregnancy in developing countries. Iron fortification of foods might be particularly useful and cost effective in settings where the logistics of oral iron supplementation among pregnant women are highly challenging. In addition, it is found very useful in developing countries where the rate of compliance with preventive treatment of iron is poor. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10782</offset><text>To this end, a variety of food items such as cereal flour (maize or wheat), salt, beverage, milk, sugar, noodles, rice, and fish sauce had been fortified with iron and used successfully as dietary supplements to boost iron stores, and hence improve haemoglobin levels in the population. Elemental iron powders are the most widely used iron compound in fortification programmes since about 50 years. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>11182</offset><text>3.3. A Review of Effectiveness of Preventive Treatments of Iron Deficiency Anaemia in Pregnancy</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>11278</offset><text>3.3.1. Prophylaxis Iron Supplements</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11314</offset><text>The overall impact of interventions on iron supplementation under field conditions has been limited and its effectiveness questioned. These concerns had been attributed to inadequate infrastructure and poor compliance with preventive treatment, among others. Furthermore, the effectiveness of this intervention has been evaluated mostly in terms of improvement in haemoglobin concentration, rather than maternal or infant health. For example, a randomized controlled trial among pregnant women in Switzerland showed that the parenteral route of iron prophylaxis of anaemia has no clinically significant benefit over oral route as there was no significant difference in maternal outcomes and serious adverse events between the two groups. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12053</offset><text>A Cochrane review of a randomized control trial conducted in Pakistan reported that daily iron treatment is better than intermittent iron supplementation in increasing haemoglobin level at delivery among pregnant women in developing countries. Findings from other studies on routine daily or weekly antenatal iron or iron plus folic acid supplementation showed that it may be of benefit, especially where pregestational iron deficiency and anaemia are prevalent. A recently published randomized study found no difference in most pregnancy outcomes between daily and twice weekly iron supplementation regimens, though the daily regimen was found to be more effective than twice weekly regimen in preventing Hb decrement at near term. The timing and dosage of oral iron are also controversial as most studies have focused on preventive treatment from midpregnancy, at or before 20 weeks gestation. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12950</offset><text>Some researchers, on the other hand, believe that both daily and weekly iron supplementation are relatively unsuccessful in the reduction of prevalence of anemia in pregnancy. They opined that sufficient attention should be paid to adolescent girls and women of reproductive age long before pregnancy and suggested intermittent low-dose iron supplements and in some cases, combined with necessary micronutrients. Apart from its effectiveness, it was argued that intermittent supplementation is more physiological by avoiding mucosal absorption block and excessive pooling of intestinal iron with associated oxidative stress; furthermore, it has logistic advantages of distribution particularly in areas of limited supply and many of the gastrointestinal side effects of daily iron are avoided. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13745</offset><text>Experiences on parenteral iron use are predominantly, but not exclusively, from the developed world as reports of its prophylactic use in pregnancy are scant; this may be related to concerns about adverse reactions associated with its use in parenteral form. However, intravenous iron sucrose in particular has been used in several recent studies and might be highly beneficial in refractory patients or those intolerant of oral iron formulations. Though, because of its immediate bioavailability, it may result in a more rapid rise in haemoglobin level in anaemic patients compared with oral iron; but it probably does not confer an advantage in preventing anaemia in pregnancy. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14426</offset><text>The WHO technical working group on the prevention and the treatment of severe anaemia has documented that parenteral iron therapy produces a rapid and complete correction of iron deficiency, including replacement of iron stores; thereby producing a more rapid erythropoietic response than oral iron replacement. However, its use should be limited to a selected group of patients who are unable to tolerate oral iron and in whom oral iron therapy fails due to noncompliance. It is also indicated in pregnant women whose hemoglobin level is required to be restored rapidly such as those who present too close to term and those who have severe anemia. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>15076</offset><text>3.3.2. Food Fortification with Iron</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15112</offset><text>Food fortification with iron has also been shown to be an equally effective strategy of boosting haemoglobin level in the population, including pregnant women. Asibey-Berko et al. in 2007 recorded 19.5% significant increase in the prevalence of anaemia among rural Ghanaian women, who were not exposed to iron-fortified salt. It was also shown that iron fortification of sugar (with mean intake of 4âmg/day) in nonpregnant Guatemalan women over three years resulted in a substantial increase in iron stores, with reserves still increasing by about 40âmg/year after the third year. Furthermore, two Vietnamese studies showed similar improvements in iron stores following ingestion of ironfortified fish sauce for six to 12 months. Comparable results were documented with dietary supplements containing iron and ironfortified milk. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>15947</offset><text>3.4. Constraints to Successful Preventive Treatments of Iron Deficiency Anaemia in Pregnancy</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>16040</offset><text>3.4.1. Side Effects of Iron Supplements</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16080</offset><text>Gastrointestinal distress is commonly observed in women consuming high levels of supplemental iron on an empty stomach. Thus, occurrence of gastrointestinal symptoms is usually considered as a critical adverse effect on which a tolerable upper intake level for iron is based for an individual. High dose of oral iron supplements is commonly associated with gastrointestinal effects such as constipation, nausea, vomiting, and diarrhea; the frequency and severity of which vary according to the amount of elemental iron released into the stomach. In addition, elevation of âfree ironâ in the plasma and hence lipid peroxidation which is indicative of oxidative stress has been reported. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16771</offset><text>Intramuscular or intravenous iron is thought to be associated with allergic reactions and anaphylactic shock; furthermore, parenteral iron is thought to predispose to venous thrombosis and occasionally cardiac arrest and death. Parenteral iron sucrose complex is known to have several advantages because of its low-allergenic properties and consequently, an extremely low incidence of severe side effects such as anaphylactic reactions; however, its use requires caution as it may not be completely devoid of side effect.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17293</offset><text>Other disadvantages of intravenous iron supplementation include cost and invasiveness of the procedure. However, it is argued that cost benefit of intravenous iron prophylaxis may be large taking into consideration the opportunity costs of erythropoiesis-stimulating agents, blood transfusions, and hospitalization. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>17610</offset><text>3.4.2. Low Utilization of Maternal Health Service in Developing Countries</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17684</offset><text>It is well established that antenatal care provides pregnant women with opportunities to receive cost-effective interventions which are beneficial to mother and child; these interventions include preventive treatments of iron deficiency anemia. However, the potentials of antenatal service have not been maximally utilized in developing countries. This is because these settings are characterized by poor maternal health service indicators such as nonutilization of service or delayed antenatal visit. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18187</offset><text>For example, researchers have reported a common occurrence of unbooked pregnancies and a wide range (60% to 90%) of antenatal care utilization rates (i.e., antenatal care clinic attendance of at least once during most recent pregnancy). In addition, for certain reasons, a substantial proportion (20% to 80%) of pregnant women in these settings make their first antenatal visit in their third trimester. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>18592</offset><text>3.4.3. Partial Implementation of Preventive Treatments</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18647</offset><text>The success of routine iron and folate supplementation, especially in areas with a high prevalence of anemia, recommended as a component of antenatal care package for all pregnant women by the World Health Organization is threatened by the practice of partial implementation of preventive treatments of health workers. Researchers have persistently reported noncompliance with this recommendation at a given antenatal visit. Van Eijk et al. in 2006 reported that 53% and 44% of pregnant women received iron and folate supplementation, respectively, during last pregnancy. Other studies reported 36â54% iron supplementation.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>19273</offset><text>3.4.4. Weak Infrastructure and Political Commitment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19325</offset><text>The efforts of World Food Programme (WFP) in overcoming micronutrient deficiencies in nutritionally-vulnerable groups and low-income food-deficit countries continue to be thwarted by challenges such as technical and managerial capacity constraints, the need for systematic compliance with procurement specifications and quality control, clearer policies on micronutrient content labeling, and the need for cash resources to support many aspects associated with local processing and fortification activities. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>19834</offset><text>3.5. Recommendations</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19855</offset><text>The World Health Organization has recommended that weekly iron and folic acid supplementation should be considered as a strategy for prevention of iron deficiency in population groups. This is particularly so where the prevalence of anemia is above 20% among women of reproductive age. Since iron tablets induce a high concentration of free radicals in the intestinal milieu, which may damage the intestinal epithelium, the minimal essential iron dose is to be recommended. Therefore, there is a need to establish effective and safe doses of supplemental iron with folic acid either as daily or weekly supplementation; this should take into consideration nutritional and haematological status of women in developing countries. Though compliance with weekly dosage may be better than daily regimen because of reduced side effects, it is desirable to conduct further field randomized controlled trials in order to establish the efficacy of weekly supplementation compared to daily regimen.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20843</offset><text>Alternatively, an equally effective, safe, and affordable iron compound with little or no side effect can be developed for use especially in public health antenatal supplementation programmes. To this end, we recommend a cue to be taken from new approaches to iron fortification technology development whereby iron-mediated undesirable taste and appearance are prevented while its stability and bioavailability are preserved. While this approach is being pursued, we recommend that appropriate measures be taken to strengthen the existing health systems in dealing with gastro-intestinal and life-threatening side effects of iron supplements.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21486</offset><text>Thus, clinical skills of local health staff could be improved through targeted trainings such as the WHO training on Life Saving Skills for health workers. Though the training lays emphasis on core midwifery skills, it could be expanded to include cardiopulmonary resuscitation of mothers; furthermore, local health staff should be provided with appropriate state-of-art equipment to work with. Although, laboratories at the health facilities in developing countries usually lack the capacity to conduct quality blood test, they could be strengthened to provide reliable estimations of red blood cell indices such as haemoglobin, haematocrit, mean cell volume, mean cell haemoglobin, and mean cell haemoglobin concentration. Where possible, estimation of serum ferritin level is desirable to adjust the dose of iron supplements. With respect to partial implementation of preventive treatment, local health staff should be encouraged on adherence to the guidelines on antenatal care package at any given antenatal visit so that partial implementation of preventive treatments is minimized.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22575</offset><text>Mass fortification programme of common local staple foods with iron and folic acid is a long-term goal, which national governments in developing countries should consider as a strategy aimed at reducing the prevalence of iron deficiency anaemia in the general population. Since iron deficiency anaemia in pregnancy is determined by preexisting body iron stores, among other factors, we recommend that the mass fortification programme should be located and implemented within the context of reproductive health services.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>23095</offset><text>4. Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>23110</offset><text>Iron deficiency remains the most important cause of anaemia in pregnancy in developing countries. Hence, its contribution to increased risks of low birth weight, prematurity, and maternal morbidity cannot be underscored. Prophylaxis iron supplement and food fortification with iron have the prospects of improving maternal and child health, except for the identified constraints. Sustained advocacy in tackling micronutrient deficiencies at national and international policy levels is also a prerequisite to the attainment of Millennium Development Goals 4 and 5.</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Iron Deficiency Anemia Assessment Prevention and Control: A Guide for Program Managers</infon><infon key="type">ref</infon><infon key="year">2001</infon><offset>23674</offset></passage><passage><infon key="issue">2</infon><infon key="name_0">surname:Reveiz;given-names:L</infon><infon key="name_1">surname:Gyte;given-names:GM</infon><infon key="name_2">surname:Cuervo;given-names:LG</infon><infon key="pub-id_other">2-s2.0-34447336726</infon><infon key="pub-id_publisher-id">CD003094</infon><infon key="section_type">REF</infon><infon key="source">Cochrane Database of Systematic Reviews</infon><infon key="type">ref</infon><infon key="year">2007</infon><offset>23675</offset><text>Treatments for iron-deficiency anaemia in pregnancy</text></passage><passage><infon key="section_type">REF</infon><infon key="source">The Prevalence of Anaemia in Women: A Tabulation of Available Information (WHO/MCH/MSM/92)</infon><infon key="type">ref</infon><infon key="year">1992</infon><offset>23727</offset></passage><passage><infon key="fpage">17</infon><infon key="lpage">24</infon><infon key="name_0">surname:McMahon;given-names:LP</infon><infon key="pub-id_pmid">27582835</infon><infon key="section_type">REF</infon><infon key="source">Obstetric Medicine</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2010</infon><offset>23728</offset><text>Iron deficiency in pregnancy</text></passage><passage><infon key="fpage">71</infon><infon key="lpage">83</infon><infon key="name_0">surname:Brabin;given-names:B</infon><infon key="pub-id_pmid">15000734</infon><infon key="section_type">REF</infon><infon key="source">Annals of Tropical Medicine and Parasitology</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="year">2004</infon><offset>23757</offset><text>Haematological profiles of the people of rural southern Malawi: an overview</text></passage><passage><infon key="fpage">701</infon><infon key="issue">6</infon><infon key="lpage">711</infon><infon key="name_0">surname:Bodnar;given-names:LM</infon><infon key="name_1">surname:Siega-Riz;given-names:AM</infon><infon key="name_2">surname:Arab;given-names:L</infon><infon key="name_3">surname:Chantala;given-names:K</infon><infon key="name_4">surname:McDonald;given-names:T</infon><infon key="pub-id_other">2-s2.0-4344716779</infon><infon key="pub-id_pmid">15369607</infon><infon key="section_type">REF</infon><infon key="source">Public Health Nutrition</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2004</infon><offset>23833</offset><text>Predictors of pregnancy and postpartum haemoglobin concentrations in low-income women</text></passage><passage><infon key="name_0">surname:Pena-Rosas;given-names:JP</infon><infon key="name_1">surname:Viteri;given-names:FE</infon><infon key="pub-id_other">2-s2.0-33750121026</infon><infon key="pub-id_publisher-id">CD004736</infon><infon key="section_type">REF</infon><infon key="source">Cochrane Database of Systematic Reviews</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2006</infon><offset>23919</offset><text>Effects of routine oral iron supplementation with or without folic acid for women during pregnancy</text></passage><passage><infon key="fpage">230</infon><infon key="issue">5</infon><infon key="lpage">239</infon><infon key="name_0">surname:Zamani;given-names:AR</infon><infon key="name_1">surname:Farajzadegan;given-names:Z</infon><infon key="name_2">surname:Ghahiri;given-names:A</infon><infon key="name_3">surname:Khademloo;given-names:M</infon><infon key="name_4">surname:Golshiri;given-names:P</infon><infon key="pub-id_other">2-s2.0-56749161093</infon><infon key="section_type">REF</infon><infon key="source">Journal of Research in Medical Sciences</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2008</infon><offset>24018</offset><text>Effectiveness of twice weekly iron supplementation compared with daily regimen in reducing anemia and iron deficiency during pregnancy: a randomized trial in Iran</text></passage><passage><infon key="issue">1</infon><infon key="name_0">surname:Halimi;given-names:S</infon><infon key="section_type">REF</infon><infon key="source">Gomal Journal of Medical Sciences</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2011</infon><offset>24181</offset><text>Oral versus parenteral iron therapy for correction of iron deficiency anaemia in preganancy</text></passage><passage><infon key="section_type">REF</infon><infon key="source">The Prevalence of Anaemia in Women: A Tabulation of Available Information</infon><infon key="type">ref</infon><infon key="year">1992</infon><offset>24273</offset></passage><passage><infon key="fpage">525</infon><infon key="issue">9</infon><infon key="lpage">532</infon><infon key="name_0">surname:Pasricha;given-names:SRS</infon><infon key="name_1">surname:Flecknoe-Brown;given-names:SC</infon><infon key="name_2">surname:Allen;given-names:KJ</infon><infon key="pub-id_other">2-s2.0-78149354075</infon><infon key="pub-id_pmid">21034387</infon><infon key="section_type">REF</infon><infon key="source">Medical Journal of Australia</infon><infon key="type">ref</infon><infon key="volume">193</infon><infon key="year">2010</infon><offset>24274</offset><text>Diagnosis and management of iron deficiency anaemia: a clinical update</text></passage><passage><infon key="fpage">765</infon><infon key="issue">6</infon><infon key="lpage">767</infon><infon key="name_0">surname:Hussar;given-names:DA</infon><infon key="pub-id_other">2-s2.0-33644790792</infon><infon key="pub-id_pmid">16381426</infon><infon key="section_type">REF</infon><infon key="source">Journal of the American Pharmacists Association</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2005</infon><offset>24345</offset><text>New drugs: pregabalin and omega-3-acid ethyl esters</text></passage><passage><infon key="fpage">51</infon><infon key="issue">1</infon><infon key="lpage">75</infon><infon key="name_0">surname:Horton;given-names:S</infon><infon key="name_1">surname:Ross;given-names:J</infon><infon key="pub-id_other">2-s2.0-0037303374</infon><infon key="section_type">REF</infon><infon key="source">Food Policy</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2003</infon><offset>24397</offset><text>The economics of iron deficiency</text></passage><passage><infon key="fpage">257S</infon><infon key="issue">1</infon><infon key="lpage">264S</infon><infon key="name_0">surname:Bothwell;given-names:TH</infon><infon key="pub-id_other">2-s2.0-0033938791</infon><infon key="pub-id_pmid">10871591</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2000</infon><offset>24430</offset><text>Iron requirements in pregnancy and strategies to meet them</text></passage><passage><infon key="fpage">1047</infon><infon key="issue">6</infon><infon key="lpage">1058</infon><infon key="name_0">surname:Hallberg;given-names:L</infon><infon key="name_1">surname:Rossander-Hulten;given-names:L</infon><infon key="pub-id_other">2-s2.0-0025790381</infon><infon key="pub-id_pmid">1957820</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">1991</infon><offset>24489</offset><text>Iron requirements in menstruating women</text></passage><passage><infon key="fpage">205</infon><infon key="issue">127</infon><infon key="lpage">214</infon><infon key="name_0">surname:Widdowson;given-names:EM</infon><infon key="name_1">surname:Spray;given-names:CM</infon><infon key="pub-id_other">2-s2.0-0000560469</infon><infon key="pub-id_pmid">14857788</infon><infon key="section_type">REF</infon><infon key="source">Archives of Disease in Childhood</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1951</infon><offset>24529</offset><text>Chemical development in utero</text></passage><passage><infon key="fpage">2</infon><infon key="lpage">5</infon><infon key="name_0">surname:Mukherji;given-names:J</infon><infon key="section_type">REF</infon><infon key="source">Rational Drug Bulletin</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2002</infon><offset>24559</offset><text>Iron deficiency anemia in pregnancy</text></passage><passage><infon key="issue">12, article 283</infon><infon key="name_0">surname:Gautam;given-names:CS</infon><infon key="name_1">surname:Saha;given-names:L</infon><infon key="name_2">surname:Sekhri;given-names:K</infon><infon key="name_3">surname:Saha;given-names:PK</infon><infon key="pub-id_other">2-s2.0-58049213920</infon><infon key="section_type">REF</infon><infon key="source">Medscape General Medicine</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2008</infon><offset>24595</offset><text>Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy</text></passage><passage><infon key="fpage">238</infon><infon key="issue">3</infon><infon key="lpage">247</infon><infon key="name_0">surname:Milman;given-names:N</infon><infon key="name_1">surname:Bergholt;given-names:T</infon><infon key="name_2">surname:Eriksen;given-names:L</infon><infon key="pub-id_other">2-s2.0-14744289682</infon><infon key="pub-id_pmid">15715531</infon><infon key="section_type">REF</infon><infon key="source">Acta Obstetricia et Gynecologica Scandinavica</infon><infon key="type">ref</infon><infon key="volume">84</infon><infon key="year">2005</infon><offset>24692</offset><text>Iron prophylaxis during pregnancy - How much iron is needed? A randomized dose-response study of 20-80 mg ferrous iron daily in pregnant women</text></passage><passage><infon key="fpage">103</infon><infon key="issue">2</infon><infon key="lpage">135</infon><infon key="name_0">surname:Milman;given-names:N</infon><infon key="pub-id_other">2-s2.0-0029965281</infon><infon key="pub-id_pmid">8867722</infon><infon key="section_type">REF</infon><infon key="source">International Journal of Hematology</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">1996</infon><offset>24835</offset><text>Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy</text></passage><passage><infon key="fpage">2298</infon><infon key="issue">8</infon><infon key="lpage">2302</infon><infon key="name_0">surname:Bodnar;given-names:LM</infon><infon key="name_1">surname:Cogswell;given-names:ME</infon><infon key="name_2">surname:Scanlon;given-names:KS</infon><infon key="pub-id_other">2-s2.0-0036322091</infon><infon key="pub-id_pmid">12163678</infon><infon key="section_type">REF</infon><infon key="source">Journal of Nutrition</infon><infon key="type">ref</infon><infon key="volume">132</infon><infon key="year">2002</infon><offset>24944</offset><text>Low income postpartum women are at risk of iron deficiency</text></passage><passage><infon key="fpage">43</infon><infon key="lpage">51</infon><infon key="name_0">surname:Puolakka;given-names:J</infon><infon key="name_1">surname:JÃ¤nne;given-names:O</infon><infon key="name_2">surname:Pakarinen;given-names:A</infon><infon key="name_3">surname:JÃ¤rvinen;given-names:PA</infon><infon key="name_4">surname:Vihko;given-names:R</infon><infon key="pub-id_other">2-s2.0-0019300665</infon><infon key="pub-id_pmid">6935911</infon><infon key="section_type">REF</infon><infon key="source">Acta Obstetricia et Gynecologica Scandinavica, Supplement</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">1980</infon><offset>25003</offset><text>Serum ferritin as a measure of iron stores during and after normal pregnancy with and without iron supplements</text></passage><passage><infon key="fpage">101</infon><infon key="issue">2</infon><infon key="lpage">107</infon><infon key="name_0">surname:Romslo;given-names:I</infon><infon key="name_1">surname:Haram;given-names:K</infon><infon key="name_2">surname:Sagen;given-names:N</infon><infon key="name_3">surname:Augensen;given-names:K</infon><infon key="pub-id_other">2-s2.0-0020684273</infon><infon key="pub-id_pmid">6824608</infon><infon key="section_type">REF</infon><infon key="source">British Journal of Obstetrics and Gynaecology</infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">1983</infon><offset>25114</offset><text>Iron requirement in normal pregnancy as assessed by serum ferritin, serum transferrin saturation and erythrocyte protoporphyrin determinations</text></passage><passage><infon key="fpage">87</infon><infon key="issue">48</infon><infon key="lpage">108</infon><infon key="name_0">surname:Svanberg;given-names:B</infon><infon key="name_1">surname:Arvidsson;given-names:B</infon><infon key="name_2">surname:Norrby;given-names:A</infon><infon key="name_3">surname:Rybo;given-names:G</infon><infon key="name_4">surname:SÃ¶lvell;given-names:L</infon><infon key="pub-id_other">2-s2.0-0016657064</infon><infon key="pub-id_pmid">1062910</infon><infon key="section_type">REF</infon><infon key="source">Acta Obstetricia et Gynecologica Scandinavica, Supplement</infon><infon key="type">ref</infon><infon key="year">1975</infon><offset>25257</offset><text>Absorption of supplemental iron during pregnancyâa longitudinal study with repeated bone-marrow studies and absorption measurements</text></passage><passage><infon key="fpage">135</infon><infon key="issue">2</infon><infon key="lpage">139</infon><infon key="name_0">surname:Bencaiova;given-names:G</infon><infon key="name_1">surname:von Mandach;given-names:U</infon><infon key="name_2">surname:Zimmermann;given-names:R</infon><infon key="pub-id_other">2-s2.0-67349084978</infon><infon key="section_type">REF</infon><infon key="source">European Journal of Obstetrics Gynecology and Reproductive Biology</infon><infon key="type">ref</infon><infon key="volume">144</infon><infon key="year">2009</infon><offset>25391</offset><text>Iron prophylaxis in pregnancy: intravenous route versus oral route</text></passage><passage><infon key="issue">4</infon><infon key="name_0">surname:PeÃ±a-Rosas;given-names:JP</infon><infon key="name_1">surname:Viteri;given-names:FE</infon><infon key="pub-id_other">2-s2.0-75349110349</infon><infon key="pub-id_publisher-id">CD004736</infon><infon key="section_type">REF</infon><infon key="source">Cochrane Database of Systematic Reviews</infon><infon key="type">ref</infon><infon key="year">2009</infon><offset>25458</offset><text>Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy</text></passage><passage><infon key="name_0">surname:Stoltzfus;given-names:RJ</infon><infon key="name_1">surname:Dreyfuss;given-names:ML</infon><infon key="section_type">REF</infon><infon key="source">Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia</infon><infon key="type">ref</infon><offset>25563</offset></passage><passage><infon key="section_type">REF</infon><infon key="source">Technical Workshop, UNICEF</infon><infon key="type">ref</infon><infon key="year">19991998</infon><offset>25564</offset><text>Preventing iron deficiency in women and children technical consensus on key issues</text></passage><passage><infon key="fpage">473</infon><infon key="issue">10</infon><infon key="lpage">480</infon><infon key="name_0">surname:Asibey-Berko;given-names:E</infon><infon key="name_1">surname:Zlotkin;given-names:SH</infon><infon key="name_2">surname:Yeung;given-names:GS</infon><infon key="pub-id_other">2-s2.0-38349093291</infon><infon key="pub-id_pmid">18232268</infon><infon key="section_type">REF</infon><infon key="source">East African Medical Journal</infon><infon key="type">ref</infon><infon key="volume">84</infon><infon key="year">2007</infon><offset>25647</offset><text>Dual fortification of salt with iron and iodine in women and children in rural Ghana</text></passage><passage><infon key="fpage">S120</infon><infon key="issue">4</infon><infon key="lpage">S128</infon><infon key="name_0">surname:Latham;given-names:MC</infon><infon key="name_1">surname:Ash;given-names:DM</infon><infon key="name_2">surname:Makola;given-names:D</infon><infon key="name_3">surname:Tatala;given-names:ST</infon><infon key="name_4">surname:Ndossi;given-names:GD</infon><infon key="name_5">surname:Mehansho;given-names:H</infon><infon key="pub-id_other">2-s2.0-0442296804</infon><infon key="pub-id_pmid">17016954</infon><infon key="section_type">REF</infon><infon key="source">Food and Nutrition Bulletin</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2003</infon><offset>25732</offset><text>Efficacy trials of a micronutrient dietary supplement in schoolchildren and pregnant women in Tanzania</text></passage><passage><infon key="fpage">32</infon><infon key="issue">1</infon><infon key="lpage">38</infon><infon key="name_0">surname:Hoa;given-names:PT</infon><infon key="name_1">surname:Khan;given-names:NC</infon><infon key="name_2">surname:van Beusekom;given-names:C</infon><infon key="name_3">surname:Gross;given-names:R</infon><infon key="name_4">surname:Conde;given-names:WL</infon><infon key="name_5">surname:Khoi;given-names:HD</infon><infon key="pub-id_other">2-s2.0-17044417250</infon><infon key="pub-id_pmid">15810797</infon><infon key="section_type">REF</infon><infon key="source">Food and Nutrition Bulletin</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2005</infon><offset>25835</offset><text>Milk fortified with iron or iron supplementation to improve nutritional status of pregnant women: an intervention trial from rural Vietnam</text></passage><passage><infon key="fpage">391</infon><infon key="issue">12</infon><infon key="lpage">406</infon><infon key="name_0">surname:Hurrell;given-names:R</infon><infon key="name_1">surname:Bothwell;given-names:T</infon><infon key="name_2">surname:Cook;given-names:JD</infon><infon key="pub-id_other">2-s2.0-0036919850</infon><infon key="pub-id_pmid">12521144</infon><infon key="section_type">REF</infon><infon key="source">Nutrition Reviews</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">2002</infon><offset>25974</offset><text>The usefulness of elemental iron for cereal flour fortification: a Sustain Task Force report</text></passage><passage><infon key="name_0">surname:Beaton;given-names:GH</infon><infon key="name_1">surname:McCabe;given-names:G</infon><infon key="section_type">REF</infon><infon key="source">The Micronutrient Initiative</infon><infon key="type">ref</infon><infon key="year">1999</infon><offset>26067</offset><text>Efficacy of intermittent iron supplementation in the control of iron deficiency anaemia in developing countries. An analysis of experience</text></passage><passage><infon key="fpage">853S</infon><infon key="issue">4, supplement</infon><infon key="lpage">855S</infon><infon key="name_0">surname:Mora;given-names:JO</infon><infon key="pub-id_other">2-s2.0-0036212559</infon><infon key="pub-id_pmid">11925496</infon><infon key="section_type">REF</infon><infon key="source">Journal of Nutrition</infon><infon key="type">ref</infon><infon key="volume">132</infon><infon key="year">2002</infon><offset>26206</offset><text>Iron supplementation: overcoming technical and practical barriers</text></passage><passage><infon key="fpage">265S</infon><infon key="issue">1, supplement</infon><infon key="lpage">271S</infon><infon key="name_0">surname:Beaton;given-names:GH</infon><infon key="pub-id_other">2-s2.0-0033934771</infon><infon key="pub-id_pmid">10871592</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2000</infon><offset>26272</offset><text>Iron needs during pregnancy: do we need to rethink our targets?</text></passage><passage><infon key="fpage">84</infon><infon key="issue">2</infon><infon key="lpage">88</infon><infon key="name_0">surname:Young;given-names:MW</infon><infon key="name_1">surname:Lupafya;given-names:E</infon><infon key="name_2">surname:Kapenda;given-names:E</infon><infon key="name_3">surname:Bobrow;given-names:EA</infon><infon key="pub-id_other">2-s2.0-0034108815</infon><infon key="pub-id_pmid">10842553</infon><infon key="section_type">REF</infon><infon key="source">Tropical Doctor</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2000</infon><offset>26336</offset><text>The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi</text></passage><passage><infon key="fpage">S65</infon><infon key="issue">12</infon><infon key="lpage">76</infon><infon key="name_0">surname:Viteri;given-names:FE</infon><infon key="name_1">surname:Berger;given-names:J</infon><infon key="pub-id_other">2-s2.0-33644864517</infon><infon key="pub-id_pmid">16466081</infon><infon key="section_type">REF</infon><infon key="source">Nutrition reviews.</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">2005</infon><offset>26428</offset><text>Importance of pre-pregnancy and pregnancy iron status: can long-term weekly preventive iron and folic acid supplementation achieve desirable and safe status?</text></passage><passage><infon key="fpage">518</infon><infon key="issue">3</infon><infon key="lpage">522</infon><infon key="name_0">surname:Bayoumeu;given-names:F</infon><infon key="name_1">surname:Subiran-Buisset;given-names:C</infon><infon key="name_2">surname:Baka;given-names:NE</infon><infon key="name_3">surname:Legagneur;given-names:H</infon><infon key="name_4">surname:Monnier-Barbarino;given-names:P</infon><infon key="name_5">surname:Laxenaire;given-names:MC</infon><infon key="pub-id_other">2-s2.0-0036126968</infon><infon key="pub-id_pmid">11904617</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Obstetrics and Gynecology</infon><infon key="type">ref</infon><infon key="volume">186</infon><infon key="year">2002</infon><offset>26586</offset><text>Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route</text></passage><passage><infon key="fpage">628</infon><infon key="issue">6</infon><infon key="lpage">631</infon><infon key="name_0">surname:Komolafe;given-names:JO</infon><infon key="name_1">surname:Kuti;given-names:O</infon><infon key="name_2">surname:Ijadunola;given-names:KT</infon><infon key="name_3">surname:Ogunniyi;given-names:SO</infon><infon key="pub-id_other">2-s2.0-0344826528</infon><infon key="pub-id_pmid">14617464</infon><infon key="section_type">REF</infon><infon key="source">Journal of Obstetrics and Gynaecology</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2003</infon><offset>26675</offset><text>A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy</text></passage><passage><infon key="fpage">424</infon><infon key="issue">7</infon><infon key="lpage">427</infon><infon key="name_0">surname:Ayub;given-names:R</infon><infon key="name_1">surname:Tariq;given-names:N</infon><infon key="name_2">surname:Adil;given-names:MM</infon><infon key="name_3">surname:Iqbal;given-names:M</infon><infon key="name_4">surname:Junaid;given-names:A</infon><infon key="name_5">surname:Jaferry;given-names:T</infon><infon key="pub-id_other">2-s2.0-52949128733</infon><infon key="pub-id_pmid">18760066</infon><infon key="section_type">REF</infon><infon key="source">Journal of the College of Physicians and Surgeons Pakistan</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2008</infon><offset>26813</offset><text>Efficacy and safety of Total Dose Infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy</text></passage><passage><infon key="fpage">1153</infon><infon key="issue">5</infon><infon key="lpage">1163</infon><infon key="name_0">surname:Viteri;given-names:FE</infon><infon key="name_1">surname:Alvarez;given-names:E</infon><infon key="name_2">surname:Batres;given-names:R</infon><infon key="pub-id_other">2-s2.0-0029066316</infon><infon key="pub-id_pmid">7733042</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="year">1995</infon><offset>26953</offset><text>Fortification of sugar with iron sodium ethylenediaminotetraacetate (FeNaEDTA) improves iron status in semirural Guatemalan populations</text></passage><passage><infon key="fpage">284</infon><infon key="issue">2</infon><infon key="lpage">290</infon><infon key="name_0">surname:Van Thuy;given-names:P</infon><infon key="name_1">surname:Berger;given-names:J</infon><infon key="name_2">surname:Davidsson;given-names:L</infon><infon key="pub-id_other">2-s2.0-0042569111</infon><infon key="pub-id_pmid">12885710</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">2003</infon><offset>27089</offset><text>Regular consumption of NaFeEDTA-fortified fish sauce improves iron status and reduces the prevalence of anemia in anemic Vietnamese women</text></passage><passage><infon key="name_0">surname:Thuy;given-names:P</infon><infon key="name_1">surname:Berger;given-names:J</infon><infon key="name_2">surname:Nakanishi;given-names:Y</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>27227</offset><text>Effectiveness of NaFeEDTA fortified fish sauce in controlling iron deficiency in Vietnam</text></passage><passage><infon key="fpage">2975</infon><infon key="issue">9</infon><infon key="lpage">2982</infon><infon key="name_0">surname:Breuer;given-names:W</infon><infon key="name_1">surname:Ronson;given-names:A</infon><infon key="name_2">surname:Slotki;given-names:IN</infon><infon key="name_3">surname:Abramov;given-names:A</infon><infon key="name_4">surname:Hershko;given-names:C</infon><infon key="name_5">surname:Cabantchik;given-names:ZI</infon><infon key="pub-id_other">2-s2.0-0034193128</infon><infon key="pub-id_pmid">10779448</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2000</infon><offset>27316</offset><text>The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation</text></passage><passage><infon key="fpage">p. A216</infon><infon key="name_0">surname:Mertz;given-names:S</infon><infon key="name_1">surname:Woodhouse;given-names:L</infon><infon key="name_2">surname:Donangelo;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">The FASEB Journal</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1999</infon><offset>27412</offset><text>Breath ethane excretion rate in young women is increased in daily iron but not in daily zinc supplementation</text></passage><passage><infon key="fpage">103</infon><infon key="issue">2</infon><infon key="lpage">110</infon><infon key="name_0">surname:Lachili;given-names:B</infon><infon key="name_1">surname:Hininger;given-names:I</infon><infon key="name_2">surname:Faure;given-names:H</infon><infon key="pub-id_other">2-s2.0-0035195363</infon><infon key="pub-id_pmid">11762527</infon><infon key="section_type">REF</infon><infon key="source">Biological Trace Element Research</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">2001</infon><offset>27521</offset><text>Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation</text></passage><passage><infon key="fpage">615</infon><infon key="issue">6</infon><infon key="lpage">621</infon><infon key="name_0">surname:Danielson;given-names:BG</infon><infon key="name_1">surname:Salmonson;given-names:T</infon><infon key="name_2">surname:Derendorf;given-names:H</infon><infon key="name_3">surname:Geisser;given-names:P</infon><infon key="pub-id_other">2-s2.0-0029894558</infon><infon key="pub-id_pmid">8767353</infon><infon key="section_type">REF</infon><infon key="source">Arzneimittel-Forschung</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">1996</infon><offset>27609</offset><text>Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers</text></passage><passage><infon key="fpage">93</infon><infon key="lpage">106</infon><infon key="name_0">surname:Danielson;given-names:B</infon><infon key="section_type">REF</infon><infon key="source">In Prevention and Management of Anaemia in Pregnancy and Postpartum Haemorrhage</infon><infon key="type">ref</infon><infon key="year">1998</infon><offset>27719</offset><text>Intravenous iron therapy-efficacy and safety of iron sucrose</text></passage><passage><infon key="fpage">267</infon><infon key="issue">6</infon><infon key="lpage">271</infon><infon key="name_0">surname:Chigbu;given-names:B</infon><infon key="name_1">surname:Onwere;given-names:S</infon><infon key="name_2">surname:Kamanu;given-names:CI</infon><infon key="name_3">surname:Aluka;given-names:C</infon><infon key="name_4">surname:Okoro;given-names:O</infon><infon key="name_5">surname:Adibe;given-names:E</infon><infon key="pub-id_other">2-s2.0-77952312118</infon><infon key="pub-id_pmid">20358788</infon><infon key="section_type">REF</infon><infon key="source">East African Medical Journal</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="year">2009</infon><offset>27780</offset><text>Pregnancy outcome in booked and unbooked mothers in South Eastern Nigeria</text></passage><passage><infon key="fpage">526</infon><infon key="issue">7</infon><infon key="lpage">531</infon><infon key="name_0">surname:Owolabi;given-names:AT</infon><infon key="name_1">surname:Fatusi;given-names:AO</infon><infon key="name_2">surname:Kuti;given-names:O</infon><infon key="name_3">surname:Adeyemi;given-names:A</infon><infon key="name_4">surname:Faturoti;given-names:SO</infon><infon key="name_5">surname:Obiajuwa;given-names:PO</infon><infon key="pub-id_other">2-s2.0-49749090113</infon><infon key="pub-id_pmid">18695859</infon><infon key="section_type">REF</infon><infon key="source">Singapore Medical Journal</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2008</infon><offset>27854</offset><text>Maternal complications and perinatal outcomes in booked and unbooked Nigerian mothers</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Nigeria Demographic and Health Survey 2008</infon><infon key="type">ref</infon><infon key="year">2009</infon><offset>27940</offset></passage><passage><infon key="section_type">REF</infon><infon key="source">Ghana Demographic and Health Survey 2008</infon><infon key="type">ref</infon><infon key="year">2009</infon><offset>27941</offset></passage><passage><infon key="fpage">p. 43</infon><infon key="name_0">surname:Babalola;given-names:S</infon><infon key="name_1">surname:Fatusi;given-names:A</infon><infon key="pub-id_other">2-s2.0-70449365726</infon><infon key="pub-id_pmid">19754941</infon><infon key="section_type">REF</infon><infon key="source">BMC Pregnancy and Childbirth</infon><infon key="type">ref</infon><infon key="volume">9, article 1471</infon><infon key="year">2009</infon><offset>27942</offset><text>Determinants of use of maternal health services in Nigeria - Looking beyond individual and household factors</text></passage><passage><infon key="name_0">surname:Van Eijk;given-names:AM</infon><infon key="name_1">surname:Bles;given-names:HM</infon><infon key="name_2">surname:Odhiambo;given-names:F</infon><infon key="pub-id_other">2-s2.0-33646588706</infon><infon key="section_type">REF</infon><infon key="source">Reproductive Health</infon><infon key="type">ref</infon><infon key="volume">3, article 2</infon><infon key="year">2006</infon><offset>28051</offset><text>Use of antenatal services and delivery care among women in rural western Kenya: a community based survey</text></passage><passage><infon key="fpage">346</infon><infon key="issue">5</infon><infon key="lpage">351</infon><infon key="name_0">surname:Osungbade;given-names:K</infon><infon key="name_1">surname:Oginni;given-names:S</infon><infon key="name_2">surname:Olumide;given-names:A</infon><infon key="pub-id_other">2-s2.0-52749090458</infon><infon key="pub-id_pmid">18621778</infon><infon key="section_type">REF</infon><infon key="source">International Journal for Quality in Health Care</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2008</infon><offset>28156</offset><text>Content of antenatal care services in secondary health care facilities in Nigeria: implication for quality of maternal health care</text></passage><passage><infon key="fpage">441</infon><infon key="issue">5</infon><infon key="lpage">452</infon><infon key="name_0">surname:Osungbade;given-names:KO</infon><infon key="name_1">surname:Shaahu;given-names:VN</infon><infon key="name_2">surname:Uchendu;given-names:OC</infon><infon key="pub-id_other">2-s2.0-79953839826</infon><infon key="pub-id_pmid">21476162</infon><infon key="section_type">REF</infon><infon key="source">Health Care for Women International</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2011</infon><offset>28287</offset><text>Clinical audit of antenatal service provision in Nigeria</text></passage><passage><infon key="fpage">67</infon><infon key="issue">1</infon><infon key="lpage">75</infon><infon key="pub-id_pmid">16572721</infon><infon key="section_type">REF</infon><infon key="source">Food and Nutrition Bulletin</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2006</infon><offset>28344</offset><text>Micronutrient fortification: WFP experiences and ways forward</text></passage><passage><infon key="issue">3, article S21</infon><infon key="name_0">surname:Yakoob;given-names:MY</infon><infon key="name_1">surname:Bhutta;given-names:ZA</infon><infon key="pub-id_other">2-s2.0-79954515995</infon><infon key="section_type">REF</infon><infon key="source">BMC Public Health</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2011</infon><offset>28406</offset><text>Effect of routine iron supplementation with or without folic acid on anemia during pregnancy</text></passage><passage><infon key="fpage">250</infon><infon key="issue">2</infon><infon key="lpage">255</infon><infon key="name_0">surname:Lund;given-names:EK</infon><infon key="name_1">surname:Wharf;given-names:SG</infon><infon key="name_2">surname:Fairweather-Tait;given-names:SJ</infon><infon key="name_3">surname:Johnson;given-names:IT</infon><infon key="pub-id_other">2-s2.0-0032921725</infon><infon key="pub-id_pmid">9989688</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Clinical Nutrition</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1999</infon><offset>28499</offset><text>Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers</text></passage><passage><infon key="fpage">1059</infon><infon key="issue">4</infon><infon key="lpage">1063</infon><infon key="name_0">surname:Mehansho;given-names:H</infon><infon key="pub-id_other">2-s2.0-33645516724</infon><infon key="pub-id_pmid">16549477</infon><infon key="section_type">REF</infon><infon key="source">Journal of Nutrition</infon><infon key="type">ref</infon><infon key="volume">136</infon><infon key="year">2006</infon><offset>28611</offset><text>Iron fortification technology development: new approaches</text></passage><passage><infon key="comment">2004, http://www.who.int/reproductive-health/publications /2004/skilled_attendant.pdf</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28669</offset><text>Making pregnancy safer: the critical role of the skilled attendant. A joint statement by WHO, ICM and FIGO</text></passage><passage><infon key="fpage">821</infon><infon key="issue">12</infon><infon key="lpage">828</infon><infon key="name_0">surname:Milman;given-names:N</infon><infon key="pub-id_other">2-s2.0-33750125260</infon><infon key="pub-id_pmid">16763841</infon><infon key="section_type">REF</infon><infon key="source">Annals of Hematology</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">2006</infon><offset>28776</offset><text>Iron prophylaxis in pregnancyâgeneral or individual and in which dose?</text></passage><passage><infon key="file">tab1.xml</infon><infon key="id">tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><offset>28849</offset><text>	Study	Study site	Subject number	Study question	Study methods	Study outcome
(1)	Zamani et al., 2008 	Iran	152 pregnant women	Twice weekly iron supplementation versus daily regimen	Randomised control trial	Haemoglobin concentration
(2)	Bencaiova et al., 2009 	Switzerland	260 pregnant women	intravenous iron sucrose versusdaily oral ferrous sulphate	Randomised control trial	Haemoglobin concentration; iron stores
(3)	Asibey-Berko et al., 2007 	Ghana	184 women	Double-fortified salt versus weekly oral iron supplement versus weekly placebo	
Double-blind randomisedcontrolled trial	Haemoglobin concentration
(4)	Hoa et al., 2005 	Vietnam	168 women	Milk fortified with iron versus milk nonfortified with iron versus iron supplementation versus placebo	Quasirandomised trial	Haemoglobin concentration
(5)	Young et al., 2000 	Malawi	413 pregnant women	Daily regimen versus weekly iron supplementation	Randomised controlled trial	Haemoglobin concentration
(6)	Latham et al., 2003 	Tanzania	Pregnant women	Micronutrient dietary supplementversus placebo	Randomised controlled trial	Iron stores
</text></passage><passage><infon key="file">tab1.xml</infon><infon key="id">tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>29936</offset><text>A list of randomised and quasi-randomised trials used for review.</text></passage></document></collection>
